Your browser doesn't support javascript.
loading
Inhibition of evi1 expression by siRNA in HEL cell line / 中国实验血液学杂志
Journal of Experimental Hematology ; (6): 1455-1459, 2010.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-332339
Responsible library: WPRO
ABSTRACT
The aim of study was to investigate the inhibitory effect of small interfering RNA on evi1 gene expression and biological characteristics in HEL cells and its mechanism. 3 siRNA (siRNA-1, siRNA-2, siRNA-3) specific for evi1 gene were synthesized and transfected into HEL cells in vitro. Experiments were divided into test and control groups. MTT method was used to assay the inhibitory effect of siRNA on cell proliferation; semiquantitative RT-PCR was used to detect the expression of evi1 gene mRNA; the cell viability was determined by trypan blue dye test; the change of cell cycle and apoptosis of cells were analyzed by flow cytometry. The results showed that siRNA-1 had strongest effect, and inhibitory effect was most obvious at 48 hours after transfection. When the concentration of siRNA raised to 120 nmol/L, the inhibitory rate reached to the peak. The inhibitory rate of siRNA-1 on proliferation of HEL cells, relative expression level of evi1 mRNA and cell viability at 48 hours after transfection were 72.22 ± 2.80%, 27.31 ± 1.11% and 26.05 ± 2.49%, which had significant difference from other groups (p < 0.001). The siRNA resulted in arrest of cell cycle at G(0)/G(1) phase, the cell amount at S phase obviously decreased, the apoptotic rate of HEL cells obviously increased (p < 0.01). It is concluded that the siRNA specific for evi1 gene can suppress the proliferation of HEL cells, reduce the expression of evi1 mRNA, decrease the cell viability, arrest the cell cycle at G(0)/G(1) phase, suppress cell mitosis, and promote cell apoptosis.
Subject(s)
Full text: Available Health context: SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases Health problem: Leukemia Database: WPRIM (Western Pacific) Main subject: Pathology / Transcription Factors / Proto-Oncogenes / RNA, Messenger / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Gene Expression Regulation, Leukemic / Cell Cycle / Apoptosis / RNA, Small Interfering / RNA Interference Limits: Humans Language: Chinese Journal: Journal of Experimental Hematology Year: 2010 Document type: Article
Full text: Available Health context: SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases Health problem: Leukemia Database: WPRIM (Western Pacific) Main subject: Pathology / Transcription Factors / Proto-Oncogenes / RNA, Messenger / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Gene Expression Regulation, Leukemic / Cell Cycle / Apoptosis / RNA, Small Interfering / RNA Interference Limits: Humans Language: Chinese Journal: Journal of Experimental Hematology Year: 2010 Document type: Article
...